Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study II

Phase 1

Active, not recruiting

Conditions: Cannabis
Alcohol Effect
Driving Under the Influence of Alcohol and Other Drugs

Interventions: Drug: Active inhaled cannabis
Drug: Active Oral Ethanol
Drug: Placebo

First Posted Date: 2016-03-16

Last Posted Date: 2025-04-15

Lead Sponsor: Yale University

Target Recruit Count: 40

Registration Number: NCT02710097

Locations: 🇺🇸
Biological Studies Unit, VA Connecticut Healthcare System, West Haven, Connecticut, United States

The Sustained Effects of Ketamine

Phase 1

Terminated

Conditions: Mental Disorders

Interventions: Drug: Ketamine
Drug: Placebo
Drug: Lamotrigine

First Posted Date: 2016-03-15

Last Posted Date: 2020-07-02

Lead Sponsor: Yale University

Target Recruit Count: 3

Registration Number: NCT02708849

Locations: 🇺🇸
Yale Center for Clinical Investigation, Yale University, New Haven, Connecticut, United States

Randomized Controlled Trial of Social Network Targeting in Honduras

Not Applicable

Completed

Conditions: Diarrhea
Preterm Delivery
Hypothermia
Upper Respiratory Infection
Omphalitis

Interventions: Behavioral: CBNH

First Posted Date: 2016-02-29

Last Posted Date: 2023-08-08

Lead Sponsor: Yale University

Target Recruit Count: 31195

Registration Number: NCT02694679

Locations: 🇭🇳
Community intervention, Copan Ruinas, Copan, Honduras
🇺🇸
Yale Institute for Network Science, New Haven, Connecticut, United States

Blood Glucose Variability and Insulin Action During Menstrual Cycle in Females With Type 1 Diabetes

Not Applicable

Completed

Conditions: Type 1 Diabetes

Interventions: Device: Follicular Euglycemic clamp
Device: Luteal Euglycemic clamp

First Posted Date: 2016-02-29

Last Posted Date: 2022-02-28

Lead Sponsor: Yale University

Target Recruit Count: 28

Registration Number: NCT02693938

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Trial Comparing Early Laparoscopic Enterolysis Versus Nonoperative Management for High-grade SBO

Phase 2

Terminated

Conditions: Small Bowel Obstruction

Interventions: Procedure: Early laparoscopic enterolysis
Procedure: nonoperative management

First Posted Date: 2016-02-26

Last Posted Date: 2020-03-02

Lead Sponsor: Yale University

Target Recruit Count: 3

Registration Number: NCT02692638

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Pharmacodynamic Study to Assess the Anti-proliferative Activity of the PARP Inhibitor Olaparib in Patients With HPV Positive and HPV Negative HNSCC

Phase 1

Withdrawn

Conditions: Squamous Cell Carcinoma of the Head and Neck

Interventions: Drug: Olaparib

First Posted Date: 2016-02-19

Last Posted Date: 2020-01-13

Lead Sponsor: Yale University

Registration Number: NCT02686008

Formative Research for an HIV Videogame for Young Black Women

Not Applicable

Completed

Conditions: HIV Prevention
STI Prevention

Interventions: Other: One Night Stan Prototype

First Posted Date: 2016-02-18

Last Posted Date: 2017-02-13

Lead Sponsor: Yale University

Target Recruit Count: 21

Registration Number: NCT02685410

Locations: 🇺🇸
Yale New Haven Hospital, New haven, Connecticut, United States

Progesterone Augmentation of Nicotine Replacement Therapy Study

Phase 4

Completed

Conditions: Smoking Cessation

Interventions: Drug: Progesterone (200 mgs BID)
Drug: Placebo

First Posted Date: 2016-02-18

Last Posted Date: 2019-07-23

Lead Sponsor: Yale University

Target Recruit Count: 64

Registration Number: NCT02685072

Locations: 🇺🇸
Yale School of Medicine, Department of Psychiatry, New Haven, Connecticut, United States

A Mail and Video-based Weight Loss Trial in Breast Cancer Survivors

Not Applicable

Completed

Conditions: Breast Cancer Survivorship
Obesity

Interventions: Behavioral: LEAN book/videos

First Posted Date: 2016-02-15

Last Posted Date: 2018-06-29

Lead Sponsor: Yale University

Target Recruit Count: 205

Registration Number: NCT02681965

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer

Phase 2

Active, not recruiting

Conditions: Non-small Cell Lung Cancer
Brain Metastasis
Melanoma

Interventions: Drug: Pembrolizumab plus Bevacizumab

First Posted Date: 2016-02-12

Last Posted Date: 2024-07-30

Lead Sponsor: Yale University

Target Recruit Count: 42

Registration Number: NCT02681549

Locations: 🇺🇸
Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, United States
🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy